{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T14:13:20Z","timestamp":1789913600968,"version":"4.0.1"},"reference-count":88,"publisher":"Elsevier BV","issue":"31","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"HPI"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.vaccine.2011.04.089","type":"journal-article","created":{"date-parts":[[2011,5,12]],"date-time":"2011-05-12T15:11:18Z","timestamp":1305213078000},"page":"5053-5064","source":"Crossref","is-referenced-by-count":61,"title":["Cellular vaccination with bone marrow-derived dendritic cells pulsed with a peptide of Leishmania infantum KMP-11 and CpG oligonucleotides induces protection in a murine model of visceral leishmaniasis"],"prefix":"10.1016","volume":"29","author":[{"given":"Maria","family":"Agallou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maritsa","family":"Margaroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evdokia","family":"Karagouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"April","key":"10.1016\/j.vaccine.2011.04.089_bib0005","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1146\/annurev.iy.09.040191.001415","article-title":"The dendritic cell system and its role in immunogenicity","volume":"9","author":"Steinman","year":"1991","journal-title":"Annu Rev Immunol"},{"issue":"July\u2013August (4)","key":"10.1016\/j.vaccine.2011.04.089_bib0010","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/PPO.0b013e3181eaca83","article-title":"Dendritic cells: are they clinically relevant?","volume":"16","author":"Palucka","year":"2010","journal-title":"Cancer J"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.04.089_bib0015","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2217\/imt.09.43","article-title":"Directing dendritic cell immunotherapy towards successful cancer treatment","volume":"2","author":"Sabado","year":"2010","journal-title":"Immunotherapy"},{"issue":"January (1\u20132)","key":"10.1016\/j.vaccine.2011.04.089_bib0020","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijmm.2007.07.003","article-title":"Mechanisms of dendritic cell-based vaccination against infection","volume":"298","author":"Fajardo-Moser","year":"2008","journal-title":"Int J Med Microbiol"},{"issue":"December (5)","key":"10.1016\/j.vaccine.2011.04.089_bib0025","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1078\/0171-2985-00105","article-title":"Dendritic cell-based vaccination strategies: induction of protective immunity against leishmaniasis","volume":"204","author":"Moll","year":"2001","journal-title":"Immunobiology"},{"issue":"suppl. 1 (November)","key":"10.1016\/j.vaccine.2011.04.089_bib0030","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1016\/j.ijantimicag.2010.06.023","article-title":"Leishmaniasis in the World Health Organization Eastern Mediterranean Region","volume":"36","author":"Postigo","year":"2010","journal-title":"Int J Antimicrob Agents"},{"issue":"November (2)","key":"10.1016\/j.vaccine.2011.04.089_bib0035","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/j.1365-2249.2005.02919.x","article-title":"Prophylactic and therapeutic vaccination with dendritic cells against hepatitis C virus infection","volume":"142","author":"Encke","year":"2005","journal-title":"Clin Exp Immunol"},{"issue":"September (5)","key":"10.1016\/j.vaccine.2011.04.089_bib0040","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1084\/jem.188.5.809","article-title":"Vaccination against chlamydial genital tract infection after immunization with dendritic cells pulsed ex vivo with nonviable Chlamydiae","volume":"188","author":"Su","year":"1998","journal-title":"J Exp Med"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2011.04.089_bib0045","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.1128\/IAI.69.7.4521-4527.2001","article-title":"Protection against pulmonary infection with Pseudomonas aeruginosa following immunization with P. aeruginosa-pulsed dendritic cells","volume":"69","author":"Worgall","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.04.089_bib0050","unstructured":"World Health Organization [Internet]. Geneva, Switzerland, c2011. Available from: http:\/\/www.who.int\/leishmaniasis\/en\/index.html."},{"issue":"September (5)","key":"10.1016\/j.vaccine.2011.04.089_bib0055","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.cimid.2004.03.004","article-title":"Leishmaniasis: current situation and new perspectives","volume":"27","author":"Desjeux","year":"2004","journal-title":"Comp Immunol Microbiol Infect Dis"},{"issue":"October (9185)","key":"10.1016\/j.vaccine.2011.04.089_bib0060","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(98)10178-2","article-title":"Leishmaniasis","volume":"354","author":"Herwaldt","year":"1999","journal-title":"Lancet"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2011.04.089_bib0065","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1128\/AAC.45.8.2185-2197.2001","article-title":"Clinical experimental advances in treatment of visceral leishmaniasis","volume":"45","author":"Murray","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2011.04.089_bib0070","first-page":"394","article-title":"Availability of miltefosine for the treatment of kala-azar in India","volume":"83","author":"Sundar","year":"2005","journal-title":"Bull World Health Organ"},{"issue":"October (4)","key":"10.1016\/j.vaccine.2011.04.089_bib0075","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1086\/318121","article-title":"Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic","volume":"31","author":"Sundar","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"August (5)","key":"10.1016\/j.vaccine.2011.04.089_bib0080","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1590\/S0074-02762007005000069","article-title":"T-cell responses associated with resistance to Leishmania infection in individuals from endemic areas for Leishmania (Viannia) braziliensis","volume":"102","author":"Bittar","year":"2007","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"August (4)","key":"10.1016\/j.vaccine.2011.04.089_bib0085","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/0952-7915(93)90033-O","article-title":"T-cell and cytokine responses in leishmaniasis","volume":"5","author":"Reed","year":"1993","journal-title":"Curr Opin Immunol"},{"issue":"March (1)","key":"10.1016\/j.vaccine.2011.04.089_bib0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1574-6968.2002.tb11101.x","article-title":"Type 1 and type 2 responses to Leishmania major","volume":"209","author":"Rogers","year":"2002","journal-title":"FEMS Microbiol Lett"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2011.04.089_bib0095","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nri933","article-title":"The immunology of susceptibility and resistance to Leishmania major in mice","volume":"2","author":"Sacks","year":"2002","journal-title":"Nat Rev Immunol"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2011.04.089_bib0100","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1590\/S0100-879X2004000400020","article-title":"Immunity and immunosuppression in experimental visceral leishmaniasis","volume":"37","author":"Goto","year":"2004","journal-title":"Braz J Med Biol Res"},{"issue":"April (8)","key":"10.1016\/j.vaccine.2011.04.089_bib0105","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.4049\/jimmunol.146.8.2763","article-title":"Differential production of Th1- and Th2-derived cytokines does not determine the genetically controlled or vaccine-induced rate of cure in murine visceral leishmaniasis","volume":"146","author":"Kaye","year":"1991","journal-title":"J Immunol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.04.089_bib0110","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1006\/expr.1996.4120","article-title":"Cloning of genes and expression and antigenicity analysis of the Leishmania infantum KMP-11 protein","volume":"85","author":"Berberich","year":"1997","journal-title":"Exp Parasitol"},{"issue":"Novenber (10)","key":"10.1016\/j.vaccine.2011.04.089_bib0115","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.4049\/jimmunol.147.10.3538","article-title":"The Leishmania donovani lipophosphoglycan T lymphocyte-reactive component is a tightly associated protein complex","volume":"147","author":"Jardim","year":"1991","journal-title":"J Immunol"},{"issue":"June (3)","key":"10.1016\/j.vaccine.2011.04.089_bib0120","first-page":"416","article-title":"Dichotomy of the human T cell response to Leishmania antigens. II. Absent or Th2-like response to gp63 and Th1-like response to lipophosphoglycan-associated protein in cells from cured visceral leishmaniasis patients","volume":"96","author":"Kurtzhals","year":"1994","journal-title":"Clin Exp Immunol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.04.089_bib0125","doi-asserted-by":"crossref","first-page":"202","DOI":"10.4049\/jimmunol.148.1.202","article-title":"Stimulation of human T lymphocytes by Leishmania lipophosphoglycan-associated proteins","volume":"148","author":"Russo","year":"1992","journal-title":"J Immunol"},{"issue":"December (6)","key":"10.1016\/j.vaccine.2011.04.089_bib0130","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.4269\/ajtmh.2010.09-0784","article-title":"Humoral and in vivo cellular immunity against the raw insect-derived recombinant Leishmania infantum antigens KMPII, TRYP, LACK, and papLe22 in dogs from an endemic area","volume":"83","author":"Todoli","year":"2010","journal-title":"Am J Trop Med Hyg"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2011.04.089_bib0135","doi-asserted-by":"crossref","first-page":"4893","DOI":"10.1128\/IAI.62.11.4893-4899.1994","article-title":"The kinetoplastid membrane protein 11 of Leishmania donovani and African trypanosomes is a potent stimulator of T-lymphocyte proliferation","volume":"62","author":"Tolson","year":"1994","journal-title":"Infect Immun"},{"issue":"April (1)","key":"10.1016\/j.vaccine.2011.04.089_bib0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0166-6851(95)00022-S","article-title":"Kinetoplastid membrane protein-11 (KMP-11) is differentially expressed during the life cycle of African trypanosomes and is found in a wide variety of kinetoplastid parasites","volume":"71","author":"Stebeck","year":"1995","journal-title":"Mol Biochem Parasitol"},{"issue":"November (2\u20133)","key":"10.1016\/j.vaccine.2011.04.089_bib0145","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0167-4781(98)00176-6","article-title":"The expression of the Leishmania infantum KMP-11 protein is developmentally regulated and stage specific","volume":"1442","author":"Berberich","year":"1998","journal-title":"Biochim Biophys Acta"},{"issue":"January (Pt 1)","key":"10.1016\/j.vaccine.2011.04.089_bib0150","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1042\/bj3050307","article-title":"Isolation and structural characterization of the Leishmania donovani kinetoplastid membrane protein-11, a major immunoreactive membrane glycoprotein","volume":"305","author":"Jardim","year":"1995","journal-title":"Biochem J"},{"issue":"January (Pt 1)","key":"10.1016\/j.vaccine.2011.04.089_bib0155","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1042\/bj3050315","article-title":"Cloning and structure-function analysis of the Leishmania donovani kinetoplastid membrane protein-11","volume":"305","author":"Jardim","year":"1995","journal-title":"Biochem J"},{"issue":"May (3)","key":"10.1016\/j.vaccine.2011.04.089_bib0160","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1590\/S0074-02762010000300018","article-title":"Kinetoplastid membrane protein-11 is present in promastigotes and amastigotes of Leishmania amazonensis and its surface expression increases during metacyclogenesis","volume":"105","author":"Matos","year":"2010","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"June (11)","key":"10.1016\/j.vaccine.2011.04.089_bib0165","doi-asserted-by":"crossref","first-page":"7160","DOI":"10.4049\/jimmunol.174.11.7160","volume":"174","author":"Basu","year":"2005","journal-title":"J Immunol"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2011.04.089_bib0170","doi-asserted-by":"crossref","first-page":"5956","DOI":"10.1128\/IAI.00944-07","article-title":"Hybrid cell vaccination resolves Leishmania donovani infection by eliciting a strong CD8+cytotoxic T-lymphocyte response with concomitant suppression of interleukin-10 (IL-10) but not IL-4 or IL-13","volume":"75","author":"Basu","year":"2007","journal-title":"Infect Immun"},{"issue":"January (3)","key":"10.1016\/j.vaccine.2011.04.089_bib0175","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0264-410X(98)90017-2","article-title":"Immunoprophylaxis and immunotherapy against experimental visceral leishmaniasis","volume":"17","author":"Mukhopadhyay","year":"1999","journal-title":"Vaccine"},{"issue":"May (9)","key":"10.1016\/j.vaccine.2011.04.089_bib0180","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1086\/513439","article-title":"HLA class I-restricted T cell epitopes of the kinetoplastid membrane protein-11 presented by Leishmania donovani-infected human macrophages","volume":"195","author":"Basu","year":"2007","journal-title":"J Infect Dis"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2011.04.089_bib0185","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1046\/j.1365-3024.2003.00626.x","article-title":"Characterizing cellular immune response to kinetoplastid membrane protein-11 (KMP-11) during Leishmania (Viannia) panamensis infection using dendritic cells (DCs) as antigen presenting cells (APCs)","volume":"25","author":"Delgado","year":"2003","journal-title":"Parasite Immunol"},{"issue":"July (1)","key":"10.1016\/j.vaccine.2011.04.089_bib0190","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1046\/j.1365-3083.1998.00370.x","article-title":"Humoral and cellular immune responses to synthetic peptides of the Leishmania donovani kinetoplastid membrane protein-11","volume":"48","author":"Jensen","year":"1998","journal-title":"Scand J Immunol"},{"issue":"April (7)","key":"10.1016\/j.vaccine.2011.04.089_bib0195","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1073\/pnas.93.7.2879","article-title":"CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma","volume":"93","author":"Klinman","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2011.04.089_bib0200","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nm0897-849","article-title":"Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants","volume":"3","author":"Roman","year":"1997","journal-title":"Nat Med"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2011.04.089_bib0205","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1002\/1521-4141(200012)30:12<3591::AID-IMMU3591>3.0.CO;2-J","article-title":"CpG-DNA activates dendritic cells in vivo: T helper cell-independent cytotoxic T cell responses to soluble proteins","volume":"30","author":"Sparwasser","year":"2000","journal-title":"Eur J Immunol"},{"issue":"August (16)","key":"10.1016\/j.vaccine.2011.04.089_bib0210","doi-asserted-by":"crossref","first-page":"9305","DOI":"10.1073\/pnas.96.16.9305","article-title":"CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cells","volume":"96","author":"Hartmann","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2011.04.089_bib0215","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1128\/IAI.67.8.3719-3726.1999","article-title":"DNA as an adjuvant in vaccination against Leishmania major","volume":"67","author":"Stacey","year":"1999","journal-title":"Infect Immun"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2011.04.089_bib0220","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1002\/eji.201040484","article-title":"A live Leishmania major vaccine containing CpG motifs induces the de novo generation of Th17 cells in C57BL\/6 mice","volume":"40","author":"Wu","year":"2010","journal-title":"Eur J Immunol"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2011.04.089_bib0225","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1002\/eji.200636472","article-title":"Immunomodulatory effects associated with a live vaccine against Leishmania major containing CpG oligodeoxynucleotides","volume":"36","author":"Wu","year":"2006","journal-title":"Eur J Immunol"},{"issue":"May (6)","key":"10.1016\/j.vaccine.2011.04.089_bib0230","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.micinf.2007.02.018","article-title":"Adoptive transfer of dendritic cells pulsed with Leishmania infantum nucleosomal histones confers protection against cutaneous leishmaniosis in BALB\/c mice","volume":"9","author":"Carrion","year":"2007","journal-title":"Microbes Infect"},{"issue":"May (10)","key":"10.1016\/j.vaccine.2011.04.089_bib0235","doi-asserted-by":"crossref","first-page":"6281","DOI":"10.4049\/jimmunol.172.10.6281","article-title":"Dendritic cells (DC) activated by CpG DNA ex vivo are potent inducers of host resistance to an intracellular pathogen that is independent of IL-12 derived from the immunizing DC","volume":"172","author":"Ramirez-Pineda","year":"2004","journal-title":"J Immunol"},{"issue":"June (2)","key":"10.1016\/j.vaccine.2011.04.089_bib0240","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.parint.2005.02.005","article-title":"Function of CD8+T lymphocytes in a self-curing mouse model of visceral leishmaniasis","volume":"54","author":"Tsagozis","year":"2005","journal-title":"Parasitol Int"},{"issue":"May\u2013June (9\u201310)","key":"10.1016\/j.vaccine.2011.04.089_bib0245","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0264-410X(97)00308-3","article-title":"ISCOMs vaccine against experimental leishmaniasis","volume":"16","author":"Papadopoulou","year":"1998","journal-title":"Vaccine"},{"issue":"February (1)","key":"10.1016\/j.vaccine.2011.04.089_bib0250","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0022-1759(98)00204-X","article-title":"An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow","volume":"223","author":"Lutz","year":"1999","journal-title":"J Immunol Methods"},{"issue":"September\u2013December (3)","key":"10.1016\/j.vaccine.2011.04.089_bib0255","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1177\/039463200401700314","article-title":"Dendritic cells pulsed with peptides of gp63 induce differential protection against experimental cutaneous leishmaniasis","volume":"17","author":"Tsagozis","year":"2004","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2011.04.089_bib0260","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-3024.2006.00817.x","article-title":"Immunohistological features of visceral leishmaniasis in BALB\/c mice","volume":"28","author":"Carrion","year":"2006","journal-title":"Parasite Immunol"},{"issue":"December (26)","key":"10.1016\/j.vaccine.2011.04.089_bib0265","doi-asserted-by":"crossref","first-page":"15050","DOI":"10.1073\/pnas.96.26.15050","article-title":"Abundant empty class II MHC molecules on the surface of immature dendritic cells","volume":"96","author":"Santambrogio","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"issue":"December (26)","key":"10.1016\/j.vaccine.2011.04.089_bib0270","doi-asserted-by":"crossref","first-page":"15056","DOI":"10.1073\/pnas.96.26.15056","article-title":"Extracellular antigen processing and presentation by immature dendritic cells","volume":"96","author":"Santambrogio","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"issue":"November (21)","key":"10.1016\/j.vaccine.2011.04.089_bib0275","doi-asserted-by":"crossref","first-page":"10188","DOI":"10.1073\/pnas.90.21.10188","article-title":"Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming","volume":"90","author":"Seder","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2011.04.089_bib0280","doi-asserted-by":"crossref","first-page":"6889","DOI":"10.4049\/jimmunol.165.12.6889","article-title":"CpG DNA induces maturation of dendritic cells with distinct effects on nascent and recycling MHC-II antigen-processing mechanisms","volume":"165","author":"Askew","year":"2000","journal-title":"J Immunol"},{"issue":"August (4)","key":"10.1016\/j.vaccine.2011.04.089_bib0285","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.4049\/jimmunol.175.4.2517","article-title":"IL-10 from regulatory T cells determines vaccine efficacy in murine Leishmania major infection","volume":"175","author":"Stober","year":"2005","journal-title":"J Immunol"},{"issue":"August (2)","key":"10.1016\/j.vaccine.2011.04.089_bib0290","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1189\/jlb.0909633","article-title":"Optimal TLR9 signal converts tolerogenic CD4-8\u2212 DCs into immunogenic ones capable of stimulating antitumor immunity via activating CD4+ Th1\/Th17 and NK cell responses","volume":"88","author":"Zhang","year":"2010","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.vaccine.2011.04.089_bib0295","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","article-title":"IL-17 and Th17 Cells","volume":"27","author":"Korn","year":"2009","journal-title":"Annu Rev Immunol"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2011.04.089_bib0300","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.immuni.2008.03.004","article-title":"The biological functions of T helper 17 cell effector cytokines in inflammation","volume":"28","author":"Ouyang","year":"2008","journal-title":"Immunity"},{"issue":"September (6)","key":"10.1016\/j.vaccine.2011.04.089_bib0305","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.4049\/jimmunol.165.6.3136","article-title":"Th1 and Th2 CD4+ T cells provide help for B cell clonal expansion and antibody synthesis in a similar manner in vivo","volume":"165","author":"Smith","year":"2000","journal-title":"J Immunol"},{"issue":"May (4804)","key":"10.1016\/j.vaccine.2011.04.089_bib0310","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1126\/science.3107127","article-title":"B cell stimulatory factor-1 reciprocally regulate Ig isotype production","volume":"236","author":"Snapper","year":"1987","journal-title":"Science"},{"issue":"August(32)","key":"10.1016\/j.vaccine.2011.04.089_bib0445","doi-asserted-by":"crossref","first-page":"14292","DOI":"10.1073\/pnas.1009234107","article-title":"Proinflammatory T helper type 17 cells are effective B-cell helpers","volume":"107","author":"Mitsdoerffer","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"issue":"November (9)","key":"10.1016\/j.vaccine.2011.04.089_bib0320","doi-asserted-by":"crossref","first-page":"5361","DOI":"10.4049\/jimmunol.173.9.5361","article-title":"Regulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of Blimp-1 and Bcl-6","volume":"173","author":"Ozaki","year":"2004","journal-title":"J Immunol"},{"issue":"November (5598)","key":"10.1016\/j.vaccine.2011.04.089_bib0325","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1126\/science.1077002","article-title":"A critical role for IL-21 in regulating immunoglobulin production","volume":"298","author":"Ozaki","year":"2002","journal-title":"Science"},{"issue":"November (9)","key":"10.1016\/j.vaccine.2011.04.089_bib0330","doi-asserted-by":"crossref","first-page":"5886","DOI":"10.4049\/jimmunol.179.9.5886","article-title":"Essential role of IL-21 in B cell activation, expansion, and plasma cell generation during CD4+ T cell-B cell collaboration","volume":"179","author":"Kuchen","year":"2007","journal-title":"J Immunol"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2011.04.089_bib0335","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.exppara.2006.09.013","article-title":"Leishmania infantum: mixed T-helper-1\/T-helper-2 immune response in experimentally infected BALB\/c mice","volume":"115","author":"Rolao","year":"2007","journal-title":"Exp Parasitol"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2011.04.089_bib0340","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1084\/jem.177.5.1505","article-title":"Recombinant interleukin 12 cures mice infected with Leishmania major","volume":"177","author":"Heinzel","year":"1993","journal-title":"J Exp Med"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2011.04.089_bib0345","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0304-4017(98)00240-4","article-title":"Immune response against Leishmania antigens in dogs naturally and experimentally infected with Leishmania infantum","volume":"81","author":"Rhalem","year":"1999","journal-title":"Vet Parasitol"},{"issue":"October (8)","key":"10.1016\/j.vaccine.2011.04.089_bib0350","doi-asserted-by":"crossref","first-page":"5592","DOI":"10.4049\/jimmunol.179.8.5592","article-title":"IL-10- and TGF-beta-mediated susceptibility in kala-azar and post-kala-azar dermal leishmaniasis: the significance of amphotericin B in the control of Leishmania donovani infection in India","volume":"179","author":"Saha","year":"2007","journal-title":"J Immunol"},{"issue":"November (5)","key":"10.1016\/j.vaccine.2011.04.089_bib0355","doi-asserted-by":"crossref","first-page":"561","DOI":"10.4269\/ajtmh.2004.71.561","article-title":"Elevated plasma levels of interferon (IFN)-gamma, IFN-gamma inducing cytokines, and IFN-gamma inducible CXC chemokines in visceral leishmaniasis","volume":"71","author":"Hailu","year":"2004","journal-title":"Am J Trop Med Hyg"},{"issue":"June (3)","key":"10.1016\/j.vaccine.2011.04.089_bib0360","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1046\/j.1365-2249.1999.00918.x","article-title":"Leishmania-specific T cells expressing interferon-gamma (IFN-gamma) and IL-10 upon activation are expanded in individuals cured of visceral leishmaniasis","volume":"116","author":"Kemp","year":"1999","journal-title":"Clin Exp Immunol"},{"issue":"October (7)","key":"10.1016\/j.vaccine.2011.04.089_bib0365","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.4049\/jimmunol.141.7.2407","article-title":"Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production","volume":"141","author":"Ding","year":"1988","journal-title":"J Immunol"},{"issue":"October (8)","key":"10.1016\/j.vaccine.2011.04.089_bib0370","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.4049\/jimmunol.161.8.4153","article-title":"Blockade of CTLA-4 enhances host resistance to the intracellular pathogen","volume":"161","author":"Murphy","year":"1998","journal-title":"Leishmania donovani. J Immunol"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2011.04.089_bib0375","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1172\/JCI116372","article-title":"In vivo cytokine profiles in patients with kala-azar. Marked elevation of both interleukin-10 and interferon-gamma","volume":"91","author":"Karp","year":"1993","journal-title":"J Clin Invest"},{"issue":"October (7)","key":"10.1016\/j.vaccine.2011.04.089_bib0380","doi-asserted-by":"crossref","first-page":"4636","DOI":"10.4049\/jimmunol.177.7.4636","article-title":"Inhibition of IL-2 induced IL-10 production as a principle of phase-specific immunotherapy","volume":"177","author":"Bodas","year":"2006","journal-title":"J Immunol"},{"issue":"October (7)","key":"10.1016\/j.vaccine.2011.04.089_bib0385","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.4049\/jimmunol.175.7.4433","article-title":"IFN-gamma controls the generation\/activation of CD4+ CD25+ regulatory T cells in antitumor immune response","volume":"175","author":"Nishikawa","year":"2005","journal-title":"J Immunol"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2011.04.089_bib0390","first-page":"1161","article-title":"Combination therapy with Paromomycin associated Stearylamine-bearing liposomes cures experimental visceral leishmaniasis through Th1-biased immunomodulation","volume":"55","author":"Banerjee","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2011.04.089_bib0395","doi-asserted-by":"crossref","first-page":"3903","DOI":"10.1128\/IAI.73.7.3903-3911.2005","article-title":"Antagonizing deactivating cytokines to enhance host defense and chemotherapy in experimental visceral leishmaniasis","volume":"73","author":"Murray","year":"2005","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2011.04.089_bib0400","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.imbio.2008.07.001","article-title":"Identification of regulatory T cells during experimental Leishmania infantum infection","volume":"214","author":"Rodrigues","year":"2009","journal-title":"Immunobiology"},{"issue":"July(7)","key":"10.1016\/j.vaccine.2011.04.089_bib0450","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nri2800","article-title":"Innate IL-17-producing cells: the sentinels of the immune system","volume":"10","author":"Cua","year":"2010","journal-title":"Nat Rev Immunol"},{"issue":"March (5)","key":"10.1016\/j.vaccine.2011.04.089_bib0410","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.4049\/jimmunol.0713598","article-title":"IL-17 promotes progression of cutaneous leishmaniasis in susceptible mice","volume":"182","author":"Lopez Kostka","year":"2009","journal-title":"J Immunol"},{"issue":"June (11)","key":"10.1016\/j.vaccine.2011.04.089_bib0415","doi-asserted-by":"crossref","first-page":"7537","DOI":"10.4049\/jimmunol.180.11.7537","article-title":"Leishmania braziliensis infection induces dendritic cell activation, ISG15 transcription, and the generation of protective immune responses","volume":"180","author":"Vargas-Inchaustegui","year":"2008","journal-title":"J Immunol"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2011.04.089_bib0420","doi-asserted-by":"crossref","first-page":"5018","DOI":"10.1128\/IAI.00499-07","article-title":"Role of interleukin-1beta in activating the CD11c(high) CD45RB- dendritic cell subset and priming Leishmania amazonensis-specific CD4+ T cells in vitro and in vivo","volume":"75","author":"Xin","year":"2007","journal-title":"Infect Immun"},{"issue":"October(10)","key":"10.1016\/j.vaccine.2011.04.089_bib0455","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1002\/eji.201040384","article-title":"Murine model of chronic L. (Viannia) panamensis infection: role of IL-13 in disease.","volume":"40","author":"Castilho","year":"2010","journal-title":"Eur J Immunol"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2011.04.089_bib0430","first-page":"2379","article-title":"IL-17 and IL-22 are associated with protection against human kala azar caused by Leishmania donovani","volume":"119","author":"Pitta","year":"2009","journal-title":"J Clin Invest"},{"issue":"February(2)","key":"10.1016\/j.vaccine.2011.04.089_bib0460","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1365-3024.2010.01256.x","article-title":"IL-17 and Regulatory Cytokines (IL-10 and IL-27) in L. braziliensis Infection","volume":"33","author":"Novoa","year":"2011","journal-title":"Parasite Immunol"},{"issue":"October(10)","key":"10.1016\/j.vaccine.2011.04.089_bib0465","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1002\/eji.200940115","article-title":"Human mucosal leishmaniasis: neutrophils infiltrate areas of tissue damage that express high levels of Th17-related cytokines","volume":"40","author":"Boaventura","year":"2010","journal-title":"Eur J Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1100644X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1100644X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,6]],"date-time":"2024-04-06T17:59:00Z","timestamp":1712426340000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1100644X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":88,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0264410X1100644X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.04.089","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}